Hiroshi Matsui to Cell Line, Tumor
This is a "connection" page, showing publications Hiroshi Matsui has written about Cell Line, Tumor.
Connection Strength
0.300
-
Rampersaud S, Fang J, Wei Z, Fabijanic K, Silver S, Jaikaran T, Ruiz Y, Houssou M, Yin Z, Zheng S, Hashimoto A, Hoshino A, Lyden D, Mahajan S, Matsui H. The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages. Nano Lett. 2016 12 14; 16(12):7357-7363.
Score: 0.089
-
Shi M, Shtraizent N, Polotskaia A, Bargonetti J, Matsui H. Impedimetric detection of mutant p53 biomarker-driven metastatic breast cancers under hyposmotic pressure. PLoS One. 2014; 9(6):e99351.
Score: 0.075
-
de la Rica R, Thompson S, Baldi A, Fernandez-Sanchez C, Drain CM, Matsui H. Label-free cancer cell detection with impedimetric transducers. Anal Chem. 2009 Dec 15; 81(24):10167-71.
Score: 0.055
-
Kang MA, Rao PP, Matsui H, Mahajan SS. Delivery of mGluR5 siRNAs by Iron Oxide Nanocages by Alternating Magnetic Fields for Blocking Proliferation of Metastatic Osteosarcoma Cells. Int J Mol Sci. 2022 Jul 19; 23(14).
Score: 0.033
-
Raghubir M, Rahman CN, Fang J, Matsui H, Mahajan SS. Osteosarcoma growth suppression by riluzole delivery via iron oxide nanocage in nude mice. Oncol Rep. 2020 01; 43(1):169-176.
Score: 0.027
-
Shtraizent N, Matsui H, Polotskaia A, Bargonetti J. Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010022.
Score: 0.021